Skip to content
Search

Latest Stories

Inhaler recycling scheme: Pharmacies in Wolverhampton join the green initiative

Inhaler recycling scheme: Pharmacies in Wolverhampton join the green initiative

Inhalers are estimated to account for three per cent of the overall NHS carbon footprint

Several pharmacies have joined the inhaler recycling scheme in Wolverhampton, West Midlands, to support NHS England’s Greener NHS programme, which aims to achieve net zero emissions by 2040.


It is part of a collaborative working initiative between the Royal Wolverhampton NHS Trust and AstraZeneca UK Ltd, supported by the Black Country Integrated Care Board and Wolverhampton City Local Pharmaceutical Committee.

Under this scheme, old and used inhalers are recycled and transformed into new products, such as coat hangers and waste bins.

Simon Evans, group chief strategy officer for The Royal Wolverhampton NHS Trust, emphasised the importance of prioritising the reduction of carbon footprint while maintaining high-quality care, to protect the planet for future generations.

“The Trust has already made significant achievements in several areas including the physical estate, clinical services, waste recycling, catering and medicines – with this inhaler recycling scheme from pharmacy being the latest string to our bow,” he said.

Janet Smith, head of sustainability for the Trust, noted that the waste team will pick up full bins on their usual routes around the city to avoid extra driving and emission of additional CO2 into the atmosphere.

Inhalers are estimated to account for three per cent of the overall NHS carbon footprint. There are different types of inhalers - short-acting beta-agonist (SABA) inhalers for immediate relief of asthma symptoms, metered dose inhalers (MDI), dry powder inhalers (DPI), and soft mist inhalers (SMI). Collectively, these inhalers contribute to over 200,000 tonnes of carbon, according to the NHS.

The propellants used in MDI inhalers contain hydrofluorocarbons (HFCs), which are potent greenhouse gases. The Royal Wolverhampton NHS Trust has cautioned that improper disposal of these inhalers could lead to the gradual leakage of the gases over time, ultimately contributing to global warming.

In 2019/20, more than 12 million inhalers were prescribed in the Midlands region.

People are encouraged to return old or used inhalers to a participating hospital or a pharmacy in Wolverhampton. At these sites, dedicated recycling bins are provided along with accompanying guidance that explains “what can and cannot be recycled.”

Inhaler Recycling Bin Community Pharmacy Image credit: The Royal Wolverhampton NHS Trust

The inhaler recycle bins are placed at New Cross and Cannock Chase Hospitals at these  dedicated sites:

  • Lloyds Pharmacy at New Cross Hospital
  • Inside the Emergency Department entrance at New Cross Hospital
  • Respiratory Centre at New Cross Hospital
  • Lloyds Pharmacy at Cannock Chase Hospital
  • Main reception at West Park Rehabilitation Hospital

Pharmacies that have joined the green initiative in Wolverhampton include Superdrug, Ettingshall Pharmacy, Mayfield Pharmacy, Morrisons Supermarket, Millstream Pharmacy, Superdrug Pharmacy, Central Pharmacy, Bradley Chemist, Upper Green Pharmacy, Lower Green Health Centre, The Pharmacy Clinic, Alpha Pharmacy, Hawthorne Chemist, and Northwood Pharmacy. Check the full list of pharmacies here.

While dropping inhalers in the recycling bins, individuals should ensure that the items are clean and not packaged in plastic bags. Additionally, people are advised to refrain from dropping the following items into the bins: inhaler spacers, any other medications, empty strips from tablets and capsules, the inhaler packaging box, paper, cardboard, and other types of plastic.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less